World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01908088
Date of registration: 23/07/2013
Prospective Registration: No
Primary sponsor: Royan Institute
Public title: Autologous Transplantation of Cultured Fibroblast on Amniotic Membrane in Patients With Epidermolysis Bullosa
Scientific title: Autologous Transplantation of Cultured Fibroblast on Amniotic Membrane for Mitten Hand Deformity in Patients With Epidermolysis Bullosa
Date of first enrolment: July 2010
Target sample size: 6
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01908088
Study type:  Interventional
Study design:  Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 1
Countries of recruitment
Iran, Islamic Republic of
Contacts
Name:     Kamal Seyed Forootan, MD
Address: 
Telephone:
Email:
Affiliation:  Plastic Surgoen, Hazrat Fatemeh Hospital
Name:     Saeed Shafiyan, MD
Address: 
Telephone:
Email:
Affiliation:  Dermatogist,Depatment of Regenerative medicin of Royan Institute
Name:     Nasser Aghdami, MD,PhD
Address: 
Telephone:
Email:
Affiliation:  Head of Royan Institute Cell Therapy Center
Name:     Zahra Orouji, MD
Address: 
Telephone:
Email:
Affiliation:  Regenerative Medicine Department of Royan Institute
Name:     Hamid Gourabi, PhD
Address: 
Telephone:
Email:
Affiliation:  Head of Royan Institute
Name:     Seyed Mohammad Javad Fatemi, MD
Address: 
Telephone:
Email:
Affiliation:  Plastic Surgoen,Hazrat Fatemeh Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- Both genders Age: 5-25y No history of other systemic disease No history of other cell
therapy method No infection in donor or recipient site HCV Ab/HIV Ab/ HBS Ag tests
were negative

Exclusion Criteria:

- Age less than 5y or more than 25y. History of other systemic disease History of other
cell therapy method Infection in donor or recipient site Positive Lab tests for
contagious viral diseases Pregnancy or lactating History of malignancy



Age minimum: 5 Years
Age maximum: 25 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Epidermolysis Bullosa With Mitten Hands
Intervention(s)
Biological: Cell transplantation
Primary Outcome(s)
Pain [Time Frame: 1month]
Healing [Time Frame: 1month]
Bleeding [Time Frame: 1week]
Infection [Time Frame: 1week]
Secondary Outcome(s)
new ulceration [Time Frame: 3months]
Range of motion [Time Frame: 6months]
Secondary ID(s)
Royan-skin-003
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Hazrat Fatemeh Hospital
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history